Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Wilson

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Medical Internet Research|March 11, 2016
Finding the Patient's Voice Using Big Data: Analysis of Users' Health-Related Concerns in the ChaCha Question-and-Answer Service (2009-2012)Chad Priest, Amelia Knopf, Doyle Groves, et al.
Open Access Journal of Clinical Trials|March 4, 2020
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's DiseaseBoris Decourt, Jeffrey Wilson, Aaron Ritter, et al.
Current Alzheimer Research|January 27, 2017
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled TrialBoris Decourt, Denise Drumm-Gurnee, Jeffrey Wilson, et al.
Annals of Emergency Medicine|August 16, 2025
Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab')<sub>2</sub> and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic AreaAri B Filip, Lina Mahmood, Collette Tilly, et al.
Biological Psychiatry|April 1, 2017
Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive ImpairmentYong Shen, Haibo Wang, Qiying Sun, et al.
The Journal of Invasive Cardiology|October 25, 2024
Heartbeats and bank statements: a survey of the financial pulse of cardiologistsBahadir Simsek, Bavana V Rangan, Yousif Ahmad, et al.
American Journal of Neurodegenerative Disease|October 5, 2013
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterationsAlex E Roher, Chera L Maarouf, Michael Malek-Ahmadi, et al.
Journal of the American Heart Association|December 19, 2018
Association Between Residential Greenness and Cardiovascular Disease RiskRay Yeager, Daniel W Riggs, Natasha DeJarnett, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2016
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and CognitionJessica R Filon, Anthony J Intorcia, Lucia I Sue, et al.
Nature Medicine|January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trialDavid Marin, Ye Li, Rafet Basar, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Medical Internet Research|March 11, 2016
Finding the Patient's Voice Using Big Data: Analysis of Users' Health-Related Concerns in the ChaCha Question-and-Answer Service (2009-2012)Chad Priest, Amelia Knopf, Doyle Groves, et al.
Open Access Journal of Clinical Trials|March 4, 2020
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's DiseaseBoris Decourt, Jeffrey Wilson, Aaron Ritter, et al.
Current Alzheimer Research|January 27, 2017
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled TrialBoris Decourt, Denise Drumm-Gurnee, Jeffrey Wilson, et al.
Annals of Emergency Medicine|August 16, 2025
Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab')<sub>2</sub> and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic AreaAri B Filip, Lina Mahmood, Collette Tilly, et al.
Biological Psychiatry|April 1, 2017
Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive ImpairmentYong Shen, Haibo Wang, Qiying Sun, et al.
The Journal of Invasive Cardiology|October 25, 2024
Heartbeats and bank statements: a survey of the financial pulse of cardiologistsBahadir Simsek, Bavana V Rangan, Yousif Ahmad, et al.
American Journal of Neurodegenerative Disease|October 5, 2013
Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterationsAlex E Roher, Chera L Maarouf, Michael Malek-Ahmadi, et al.
Journal of the American Heart Association|December 19, 2018
Association Between Residential Greenness and Cardiovascular Disease RiskRay Yeager, Daniel W Riggs, Natasha DeJarnett, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2016
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and CognitionJessica R Filon, Anthony J Intorcia, Lucia I Sue, et al.
Nature Medicine|January 18, 2024
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19<sup>+</sup> B cell tumors: a phase 1/2 trialDavid Marin, Ye Li, Rafet Basar, et al.
Pageof 7